Post job

Dana-Farber Cancer Institute CEO and executives

Executive Summary. Based on our data team's research, Laurie H. Glimcher is the Dana-Farber Cancer Institute's CEO. Dana-Farber Cancer Institute has 6,560 employees, of which 64 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Dana-Farber Cancer Institute executive team is 42% female and 58% male.
  • 65% of the management team is White.
  • 14% of Dana-Farber Cancer Institute management is Hispanic or Latino.
  • 12% of the management team is Black or African American.
Work at Dana-Farber Cancer Institute?
Share your experience

Rate Dana-Farber Cancer Institute's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Laurie H. Glimcher

President/CEO

Laurie H. Glimcher's LinkedIn

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana-Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.

Sidney Farber

Founder

Tracey Flaherty

Founder

Stephen E. Sallan

Chief of Staff

Stephen E. Sallan's LinkedIn

Stephen Sallan works at Dana-Farber Cancer Institute and a Chief of Staff at Dana-Farber Cancer Institute and is based in Greater Boston Area.

Benjamin Ebert

MD

Craig A. Bunnell

MD

Gerard M. Doherty

MD, Chair of Surgery

William C. Hahn

MD

William C. Hahn's LinkedIn

William C. Hahn, MD, PhD, has been engaged in clinical care and research at Dana-Farber since 1996. He is the William Rosenberg Professor of Medicine and an Institute Member of the Broad Institute of MIT and Harvard. He received his AB in Biochemical Sciences, PhD in Immunology, and MD all from Harvard University and completed his clinical training at Massachusetts General Hospital and Dana-Farber Cancer Institute. His research focuses on understanding how mutations cooperate in cancer initiation and progression to develop rational combination therapies.

Atul Shinagare

MD

Barrett J. Rollins

MD

Do you work at Dana-Farber Cancer Institute?

Does leadership effectively guide Dana-Farber Cancer Institute toward its goals?

Dana-Farber Cancer Institute jobs

Dana-Farber Cancer Institute founders

Name & TitleBio
Sidney Farber

Founder

Tracey Flaherty

Founder

Dana-Farber Cancer Institute board members

Name & TitleBio
Benjamin Ebert

MD

Gerard M. Doherty

MD, Chair of Surgery

Bill Karol

Board Member

Brian Knez

Board Member

Edward Rover

Board Member

Harvey Berger

Board Member

Helena Foulkes

Board Member

Jane Jamieson

Board Member

Jean Tempel

Board Member

Joshua Bekenstein

Board Member

Dana-Farber Cancer Institute leadership demographics

Dana-Farber Cancer Institute gender distribution in management team

  • The Dana-Farber Cancer Institute executive team is 42% female and 58% male.
  • Dana-Farber Cancer Institute is 69% female and 31% male company-wide.
Male
Male
58%
Company-wide: 31%
Female
Female
42%
Company-wide: 69%

Dana-Farber Cancer Institute executives by race

Management Team:
  • The most common ethnicity among Dana-Farber Cancer Institute executive officers is White.
  • 65% of the management team is White.
  • 14% of Dana-Farber Cancer Institute's management is Hispanic or Latino.
  • 12% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 63% of employees are White.
  • 14% of employees are Hispanic or Latino.
  • 13% of employees are Asian.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Dana-Farber Cancer Institute jobs nearby

Dana-Farber Cancer Institute executives FAQs

Zippia gives an in-depth look into the details of Dana-Farber Cancer Institute, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dana-Farber Cancer Institute. The employee data is based on information from people who have self-reported their past or current employments at Dana-Farber Cancer Institute. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dana-Farber Cancer Institute. The data presented on this page does not represent the view of Dana-Farber Cancer Institute and its employees or that of Zippia.

Dana-Farber Cancer Institute may also be known as or be related to DANA-FARBER CANCER CARE NETWORK INC, Dana-Farber Cancer Institute and President and Fellows of Harvard College.